Italian multicenter study on reversible cerebral ischemic attacks: VI--Prognostic factors and follow-up results.

Italian multicenter study on reversible cerebral ischemic attacks: population characteristics and methodology.

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.

BACKGROUND AND PURPOSE This subgroup analysis from the Ticlopidine Aspirin Stroke Study (TASS) compared ticlopidine, a new antiplatelet agent, with aspirin for the prevention of recurrent transient ischemic attacks in patients who had a recent reversible cerebrovascular event. METHODS This was a multicenter, double-blind, randomized trial in patients with a recent cerebral ischemic history. P...

Assessment of inter-observer differences in the Italian multicenter study on reversible cerebral ischemia.

A standardized protocol was used for duplicate examination by two neurologists of the clinical history and neurological signs in 55 patients with reversible cerebral ischemia. One trained examiner from each of eight clinical centres involved in the Italian Cooperative Study on reversible cerebral ischemia participated in this research. Duplicate examination were compared in order to evaluate th...

The Italian Multicenter Study of reversible cerebral ischemic attacks: IV--Blood pressure components and atherosclerotic lesions.

Utilizing the initial BP assessment in the 462 patients who entered the Italian Multicenter Study of reversible cerebral ischemia, an analysis of the effect of each BP component in respect of presence, extent and severity of atherosclerotic lesions, as displayed by angiography, was carried out separately for lesions located at either intra- or extracranial level. In a multivariate statistical m...

Research in Progress Italian Multicenter Study on Reversible Cerebral Ischemic Attacks: Population Characteristics and Methodology

CEREBRAL VASCULAR DISEASES in Italy have a mortality rate of 136/100,000/year, representing 15% of all deaths: these data, registered in 1975, do not differ from those of other countries. Preventive treatment of patients at risk is a guideline to reduce incidence and mortality of such severe diseases. Patients with focal reversible cerebral ischemia (RIA) are considered those typically at risk ...